Raymond J. Bartoszek - 23 Jun 2025 Form 4 Insider Report for KINETA, INC./DE (KANT)

Role
Director
Signature
/s/ Nanette Agustines, as Attorney-in-Fact
Issuer symbol
KANT
Transactions as of
23 Jun 2025
Net transactions value
+$6,414
Form type
4
Filing time
25 Jun 2025, 21:45:00 UTC
Previous filing
05 Sep 2024
Next filing
02 Jul 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Bartoszek Raymond J. Director C/O KINETA, INC., 7683 SE 27TH STREET, SUITE 481, MERCER ISLAND /s/ Nanette Agustines, as Attorney-in-Fact 25 Jun 2025 0001730052

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KANT Common Stock Options Exercise $7,638 +12,500 +73% $0.6110 29,706 23 Jun 2025 Direct
transaction KANT Common Stock Tax liability $1,224 -4,706 -16% $0.2600 25,000 23 Jun 2025 Direct
transaction KANT Common Stock Award $0 +6,000 +24% $0.000000 31,000 25 Jun 2025 Direct
holding KANT Common Stock 1,748,473 23 Jun 2025 By RLB Holdings Connecticut, LLC F1
holding KANT Common Stock 1,001 23 Jun 2025 By son
holding KANT Common Stock 1,000 23 Jun 2025 By daughter

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KANT Stock Option (Right to Buy) Options Exercise $0 -12,500 -100% $0.000000 0 23 Jun 2025 Common Stock 12,500 $0.6110 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person is a managing member of RLB Holdings Connecticut, LLC ("RLB") and shares voting and dispositive power over the shares held by RLB. As such, the Reporting Person may be deemed to beneficially own such shares held by RLB.
F2 Pursuant to the terms of (i) the Optionholder Treatment Agreement, dated June 16, 2025, by and between Kineta, Inc. (the "Company") and the Reporting Person, and (ii) the Agreement and Plan of Merger, dated as of December 11, 2024, by and among the Company, TuHURA Biosciences, Inc., a Nevada corporation ("TuHURA"), Hura Merger Sub I, Inc., a Delaware corporation and a wholly owned subsidiary of TuHURA, Hura Merger Sub II, a Delaware limited liability company and a wholly owned subsidiary of TuHURA, and Craig Philips, as representative of the stockholders of the Company, and as amended by that certain First Amendment to Agreement and Plan of Merger, dated May 5, 2025, as approved by the Company's stockholders at the Special Meeting of Stockholders held on June 23, 2025, the options granted to the Reporting Person under the 2022 Equity Incentive Plan became fully vested on June 23, 2025.